FibroGen (FGEN) Reaches $50.15 After 7.00% Up Move; American Water Works Company (AWK) Sentiment Is 1.04

August 8, 2017 - By Ellis Scott

American Water Works Company, Inc. is a holding firm for regulated and market subsidiaries throughout the United States and Ontario, Canada. The company has market cap of $14.52 billion. The Company’s Regulated Businesses segment provides water and wastewater services as public utilities in 16 states in the United States as of December 31, 2016. It has a 30.76 P/E ratio. The Market-Based Businesses consists of four divisions, including Military Services Group, which conducts operation and maintenance of water and wastewater systems for military bases; Contract Operations Group, which conducts O&M of water and wastewater facilities for municipalities and the food and beverage industry; Homeowner Services Group, which primarily provides water and sewer line protection plans for homeowners, and Keystone, which provides water services for natural gas exploration and production companies.

The stock of FibroGen Inc (NASDAQ:FGEN) is a huge mover today! About 3.93 million shares traded or 879.99% up from the average. FibroGen Inc (NASDAQ:FGEN) has risen 52.86% since August 8, 2016 and is uptrending. It has outperformed by 36.16% the S&P500.The move comes after 6 months positive chart setup for the $3.51 billion company. It was reported on Aug, 8 by Barchart.com. We have $53.66 PT which if reached, will make NASDAQ:FGEN worth $245.70M more.

Analysts await FibroGen Inc (NASDAQ:FGEN) to report earnings on August, 14. They expect $-0.47 EPS, down 234.29% or $0.82 from last year’s $0.35 per share. After $-0.52 actual EPS reported by FibroGen Inc for the previous quarter, Wall Street now forecasts -9.62% EPS growth.

Among 6 analysts covering FibroGen Inc (NASDAQ:FGEN), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. FibroGen Inc had 10 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Goldman Sachs on Friday, July 21. The rating was initiated by Lake Street on Wednesday, September 23 with “Hold”. The firm has “Buy” rating by Citigroup given on Wednesday, July 29. The rating was initiated by Credit Suisse with “Neutral” on Thursday, January 21. The stock of FibroGen Inc (NASDAQ:FGEN) earned “Outperform” rating by Credit Suisse on Thursday, February 11. The stock has “Buy” rating by Citigroup on Friday, December 4.

FibroGen, Inc. is a science-based biopharmaceutical company. The company has market cap of $3.51 billion. The Firm is engaged in the discovery, development and commercialization of therapeutics to treat serious unmet medical needs. It currently has negative earnings. The Company’s lead product candidate is roxadustat .

Water Asset Management Llc holds 16.71% of its portfolio in American Water Works Company Inc for 342,128 shares. Partners Group Holding Ag owns 595,390 shares or 6.42% of their US portfolio. Moreover, Trellus Management Company Llc has 5.5% invested in the company for 51,600 shares. The United Kingdom-based Impax Asset Management Ltd has invested 4.27% in the stock. Reaves W H & Co Inc, a New Jersey-based fund reported 1.31 million shares.

Since January 1, 0001, it had 0 insider purchases, and 5 sales for $2.05 million activity.